))
From Medicine to Biotech: Dr. Vitoc's Quest for Cancer Breakthroughs
Fetch error
Hmmm there seems to be a problem fetching this series right now.
Last successful fetch was on November 09, 2024 01:21 (
What now? This series will be checked again in the next hour. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.
Manage episode 442181454 series 3563546
Indhold leveret af Donald Davis, PhD and Don Davis. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af Donald Davis, PhD and Don Davis eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.
In this episode of the Life Science Success Podcast, my guest is Dr. Vlad Vitoc, Chairman of the Board, CEO, and President of MAIA Biotechnology. Dr. Vitoc shares his journey from practicing medicine in Romania to leading a cutting-edge biotech company in the United States. We explore MAIA Biotechnology's innovative approach to cancer treatment, focusing on telomere-targeting therapeutics and their lead compound, THIO. Dr. Vitoc offers insights into the challenges of developing new cancer therapies, the future of targeted treatments, and how his international background influences his leadership style.
He also discusses the balance between scientific innovation and commercial viability in the biotech industry. This episode provides a fascinating look into the intersection of medical expertise, business acumen, and scientific innovation in the fight against cancer.
00:00 Introduction to Life Science Success Podcast 00:43 Sponsor Message from D3 Digital Media Marketing 01:24 Introducing Dr. Vlad Vitoc 02:00 Dr. Vitoc's Journey in Oncology 10:08 Innovations in Cancer Treatment 17:20 Challenges and Future Plans 26:35 Global Clinical Development Strategy 28:11 Closing Remarks and Reflections 40:16 Podcast Conclusion and Call to Action
100 episoder
Del
